Editorial standards

Evidence before interpretation.

A repeatable process for an emerging field.

Source hierarchy

Original peer-reviewed papers support clinical findings. Trial registries support protocol and status reporting. Regulators establish jurisdiction-specific decisions. Filed financial statements and exchange disclosures support corporate reporting. Sponsor releases are labelled as sponsor reports; they are not independent confirmation.

Five verification gates

1. Identify the original record and its DOI, trial ID or filing accession.
2. Record event date, publication date and date checked. Compare with the previous record; deduplicate.
3. Extract population, design, endpoints, denominators, uncertainty, safety, funding and limitations.
4. Match every substantive claim to its source; label inference and reject unsupported generalisations.
5. Complete editorial review, conflicts disclosure and owner approval before publication or email.

Discovery routes

PubMed and original publishers; ClinicalTrials.gov; FDA, EMA and TGA; SEC EDGAR and relevant exchange filings. Discovery alone does not validate a claim.

Evidence labels

Peer-reviewed human trial · Registry record · Preclinical · Preprint · Regulator statement · Sponsor-reported · Company filing · Editorial interpretation. Evidence types are described rather than collapsed into a misleading numeric score.

Corrections and disclosures

Material corrections will be dated and explained on the article and in the next issue. Owner holdings and commercial conflicts must be declared before release. We do not assume there are no conflicts. Send corrections and disclosure enquiries to hello@peptidecheat.com.

Scope

Educational reporting, not individual medical, legal or investment advice. No self-experimentation instructions. Absence of evidence is reported as such.